Vulnerable Populations: Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada
Alexis Crabtree, Emily Lostchuck, Mei Chong, Aaron Shapiro and Amanda Slaunwhite
CMAJ August 24, 2020 192:E967-E972
[PDF]
Vulnerable Populations: A safer drug supply: a pragmatic and ethical response to the overdose crisis
Mark Tyndall
CMAJ August 24, 2020 192:E986-E987
[PDF]
SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
Paul Van Caeseele, for the Canadian Public Health Laboratory Network, Dana Bailey, for the Canadian Society of Clinical Chemists, Sarah E. Forgie, for the Association of Medical Microbiology and Infectious Disease Canada, Tanis C. Dingle, for the Canadian Association for Clinical Microbiology and Infectious Diseases, Mel Krajden and for the COVID-19 Immunity Task Force
CMAJ August 24, 2020 192:E973-E979
[PDF]
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
Bahaa Abu-Raya, Soren Gantt and Manish Sadarangani
CMAJ August 24, 2020 192:E982-E985
[PDF]
Five things to know about ...: Placenta accreta spectrum
Valerie Bloomfield, Stacey Rogers and Nicholas Leyland
CMAJ August 24, 2020 192:E980
[PDF]
Clinical Images: Minocycline-induced cutaneous hyperpigmentation
Lauren Shute, Andrew Walkty and John M. Embil
CMAJ August 24, 2020 192:E981
[PDF]
Encounters: The gift of peace
Alexander Kmet
CMAJ August 24, 2020 192:E989-E990
[PDF]
This is way more complicated than anyone expected ...
Terry Murray
CMAJ August 24, 2020 192:E991-E992
[PDF]
Why are Indigenous communities seeing so few cases of COVID-19?
Jolene Banning
CMAJ August 24, 2020 192:E993-E994
[PDF]
Safely restarting renal transplant programs should be a priority
Daniel Fantus and Michel R. Pâquet
CMAJ August 24, 2020 192:E988
[PDF]